iSyncWave is a gel-free, portable EEG brain mapping device with LED photo-biomodulators.
It will also allow for individuals to facilitate regular check-ups to prevent degenerative neurological disorders
South Korean biomedic start-up iMediSync has designed an EEG digital biomarker for early detection of Alzheimer’s dementia on its AI cloud platform. The company will showcase iSyncWave – the EEG (electroencephalogram) brain mapping and LED-therapeutic device – at CES 2021. It will also demonstrate its version of virtual care that allows healthcare providers to monitor patients remotely.
iSyncWave is a gel-free, portable EEG brain mapping device with LED photo-biomodulators. Designed especially for the early detection and supportive care of neuropsychiatric disorders such as dementia, Parkinson’s disease, TBI, PTSD, ADHD, depression, etc., it is believed to help neuropsychiatric patients to treat their illnesses at both clinics and homes. It will also allow for individuals to facilitate regular check-ups to prevent degenerative neurological disorders.
Published by ImediSync, January 12, 2021
Follow us on Linkedin!